Format

Send to

Choose Destination
Nat Rev Immunol. 2010 Jul;10(7):527-35. doi: 10.1038/nri2801.

Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.

Author information

1
Veterans Affairs New York Harbor Healthcare System, Manhattan Campus, New York 10010, USA. Susan.Zolla-Pazner@nyumc.org

Abstract

One of the main challenges of developing an HIV-1 vaccine lies in eliciting immune responses that can overcome the antigenic variability exhibited by HIV. Most HIV-1 vaccine development has focused on inducing immunity to conserved regions of the HIV-1 envelope. However, new studies of the sequence-variable regions of the HIV-1 gp120 envelope glycoprotein have shown that there are conserved immunological and structural features in these regions. Recombinant immunogens that include these features may provide the means to address the antigenic diversity of HIV-1 and induce protective antibodies that can prevent infection with HIV-1.

PMID:
20577269
PMCID:
PMC3167078
DOI:
10.1038/nri2801
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center